Skip to menu Skip to content Skip to footer
  • UQ Home
  • Contacts
  • Study
  • Maps
  • News
  • Events
  • Library
  • Give now
  • my.UQ
The University of Queensland
Institute for Molecular Bioscience Institute for Molecular Bioscience
Site search
Site search
Menu
  • Home
  • About
    • Annual reports
    • Careers
    • Dare to imagine
  • Our People
    • Executive
    • Research leaders
    • Boards
    • Diversity & Inclusion committee
    • Women in science
    • Alumni
    • Ambassadors
    • EMCRs
  • Research
    • Research groups
    • Facilities
      • Microscopy
      • Mass Spectrometry
      • Queensland Facility for Advanced Genome Editing
      • Queensland Facility for Advanced Bioinformatics (QFAB)
      • Queensland Emory Drug Discovery Initiative
      • Clive & Vera Ramaciotti Facility for Producing Pharmaceuticals in Plants
      • Centre for Solar Biotechnology Facility
      • Sequencing facility
    • Research centres
    • Research partnerships
  • Partner
  • Study
    • Higher Degrees by Research (PhD/MPhil)
    • Global Challenges PhD Scholarship
    • Masters by coursework
    • Honours
    • Undergraduate
    • SIMBA
  • Stories
    • News
    • The Edge Magazine - Infection
    • The Edge Magazine - Inflammation
    • Podcasts
    • Covid research
    • Venom
    • Endometriosis
  • Get Involved
    • Donate to our research
    • Events
    • Corporate partnerships
    • Talks & Tours
    • Director's Circle
    • Philanthropy in action
    • Ignite Innovation
    • Soils for Science
  • Give
  • Contact

Ms Miranda Pitt

Higher degree by research (PhD) student
Institute for Molecular Bioscience
+61 7 334 62178
miranda.pitt@imb.uq.edu.au

Publications

Journal Articles (11)
Thesis (1)

Journal Articles

Chang, Jessie J.-Y., Gleeson, Josie, Rawlinson, Daniel, De Paoli-Iseppi, Ricardo, Zhou, Chenxi, Mordant, Francesca L., Londrigan, Sarah L., Clark, Michael B., Subbarao, Kanta, Stinear, Timothy P., Coin, Lachlan J. M. and Pitt, Miranda E. (2022). Long-read RNA sequencing identifies polyadenylation elongation and differential transcript usage of host transcripts during SARS-CoV-2 in vitro infection. Frontiers in Immunology, 13 832223, 832223. doi: 10.3389/fimmu.2022.832223
Li, Fuyi, Guo, Xudong, Xiang, Dongxu, Pitt, Miranda E., Bainomugisa, Arnold and Coin, Lachlan J.M. (2022). Computational analysis and prediction of PE_PGRS proteins using machine learning. Computational and Structural Biotechnology Journal, 20, 662-674. doi: 10.1016/j.csbj.2022.01.019
Chang, Jessie J.-Y., Rawlinson, Daniel, Pitt, Miranda E., Taiaroa, George, Gleeson, Josie, Zhou, Chenxi, Mordant, Francesca L., De Paoli-Iseppi, Ricardo, Caly, Leon, Purcell, Damian F.J., Stinear, Timothy P., Londrigan, Sarah L., Clark, Michael B., Williamson, Deborah A., Subbarao, Kanta and Coin, Lachlan J.M. (2021). Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection. Cell Reports, 35 (6) 109108, 1-18. doi: 10.1016/j.celrep.2021.109108
Pitt, Miranda E., Nguyen, Son H., Duarte, Tânia P. S., Roddam, Louise F., Blaskovich, Mark A. T., Cooper, Matthew A. and Coin, Lachlan J. M. (2020). Complete genome sequences of clinical Pandoraea fibrosis isolates. Microbiology Resource Announcements, 9 (13) e00060-20. doi: 10.1128/mra.00060-20
Pitt, Miranda E., Nguyen, Son H., Duarte, Tânia P. S., Teng, Haotian, Blaskovich, Mark A. T., Cooper, Matthew A. and Coin, Lachlan J. M. (2020). Evaluating the genome and resistome of extensively drug-resistant Klebsiella pneumoniae using native DNA and RNA Nanopore sequencing. GigaScience, 9 (2), 1-14. doi: 10.1093/gigascience/giaa002
Bialasiewicz, Seweryn, Duarte, Tania P. S., Nguyen, Son H., Sukumaran, Vichitra, Stewart, Alexandra, Appleton, Sally, Pitt, Miranda E., Bainomugisa, Arnold, Jennison, Amy V., Graham, Rikki, Coin, Lachlan J. M. and Hajkowicz, Krispin (2019). Rapid diagnosis of Capnocytophaga canimorsus septic shock in an immunocompetent individual using real-time Nanopore sequencing: a case report. BMC Infectious Diseases, 19 (1) 660, 1-5. doi: 10.1186/s12879-019-4173-2
Pitt, Miranda E., Cao, Minh Duc, Butler, Mark S., Ramu, Soumya, Ganesamoorthy, Devika, Blaskovich, Mark A. T., Coin, Lachlan J. M. and Cooper, Matthew A. (2018). Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate. The Journal of Antimicrobial Chemotherapy, 74 (3), 582-593. doi: 10.1093/jac/dky458
Blaskovich, Mark A. T., Pitt, Miranda E., Elliott, Alysha G. and Cooper, Matthew A. (2018). Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?. Expert Review of Anti-infective Therapy, 16 (6), 485-499. doi: 10.1080/14787210.2018.1483240
Pitt, Miranda E., Elliott, Alysha G., Cao, Minh Duc, Ganesamoorthy, Devika, Karaiskos, Ilias, Giamarellou, Helen, Abboud, Cely S., Blaskovich, Mark A. T., Cooper, Matthew A. and Coin, Lachlan J. M. (2018). Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae. Microbial Genomics, 4 (3) 000158. doi: 10.1099/mgen.0.000158
Tseng, Hsu-Wen, Pitt, Miranda E., Glant, Tibor T., McRae, Allan F., Kenna, Tony J., Brown, Matthew A., Pettit, Allison R. and Thomas, Gethin P. (2016). Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes. Arthritis Research and Therapy, 18 (1) 35, 35. doi: 10.1186/s13075-015-0805-0
Phetsang, Wanida, Pelingon, Ruby, Butler, Mark S., KC, Sanjaya, Pitt, Miranda, Kaeslin, Geraldine, Cooper, Matthew A. and Blaskovich, Mark A. T. (2016). Fluorescent trimethoprim conjugate probes to assess drug accumulation in wild type and mutant Escherichia coli. ACS Infectious Diseases, 2 (10), 688-701. doi: 10.1021/acsinfecdis.6b00080

Thesis

Pitt, Miranda Elise (2018). Evaluating genotypic and phenotypic variability against polymyxins and a novel lipopeptide, octapeptin C4, in antibiotic-resistant Klebsiella pneumoniae. PhD Thesis, Institute for Molecular Bioscience, The University of Queensland. doi: 10.14264/uql.2018.817
© The University of Queensland
Enquiries: +61 7 3365 1111   |   Contact directory
ABN: 63 942 912 684   |   CRICOS Provider No: 00025B
Emergency
Phone: 3365 3333
Privacy & Terms of use   |   Feedback   |   Updated: 29 Jul 2020
Login